Results for untargeted MS search on m/z: (+/-) mode
Details | Name | m/z | RT | RT_Units | Study | Ion_mode | MS_Instrument | Chromatography | Species | Source |
---|---|---|---|---|---|---|---|---|---|---|
AN002734 | 369.1692032 | 2.91 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 369.1693255 | 2.31 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | CE(18:1) | 369.350092 | 9.16 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | CE(18:2) | 369.3502212 | 8.77 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 369.3508264 | 5.97 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | CE(16:0) | 369.3511757 | 9.31 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 372.2435458 | 2.75 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 376.314731 | 5.33 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 376.3169477 | 3.22 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 377.1356317 | 2.43 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 379.1507783 | 2.32 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 380.2769046 | 3.37 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 382.3673273 | 3.56 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 385.2968663 | 6.95 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 387.182144 | 2.31 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 387.1925023 | 2.36 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 391.1523557 | 2.42 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 395.1246599 | 2.32 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 396.331414 | 2.84 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 401.286874 | 2.84 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 409.1614896 | 2.12 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 409.161817 | 2.31 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 419.2395669 | 2.24 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 421.3219702 | 4.64 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 422.3970789 | 3.77 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 422.3985228 | 5.67 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 425.2140338 | 2.92 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 426.1380429 | 1.94 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 435.2134756 | 2.24 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 436.3398459 | 4.21 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 437.1948176 | 3.81 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 440.3574922 | 2.82 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 440.4093882 | 4.01 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 449.184599 | 2.88 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 450.4297594 | 6.45 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 468.4407187 | 4.77 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 473.3177951 | 4.37 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 474.2824088 | 7.76 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 476.3272824 | 4.43 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 478.3978759 | 2.22 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | LPC(16:0e) | 482.3605909 | 3.46 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 482.4045069 | 5.17 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 483.4074062 | 7.94 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 484.3836912 | 2.8 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 489.2263934 | 2.91 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | LPC(16:0) | 496.3393953 | 3.23 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 496.4708684 | 5.53 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 503.8866535 | 5.22 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 503.8867796 | 5.06 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 512.414841 | 6.47 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 517.3561066 | 4.43 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 517.9029545 | 5.72 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 517.9031615 | 5.85 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | Cer(d18:1/16:0) | 520.5081288 | 6.48 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 521.2901556 | 3.2 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 521.4546394 | 8.37 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | LPC(18:1) | 522.3543706 | 3.2 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 523.287789 | 3.2 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | LPC(18:0) | 524.3700688 | 3.7 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 526.4304457 | 8.73 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | Cer(d35:1) | 534.5239244 | 6.7 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 535.5083759 | 9.1 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 537.5345602 | 8.05 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 537.5345604 | 8.26 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 537.5345637 | 7.41 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 537.5345751 | 9.92 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 537.5345842 | 10.06 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 537.5345952 | 11.06 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 539.5405494 | 9.62 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 539.5406206 | 8.87 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 539.5406327 | 9.71 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 539.5406953 | 8.7 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 540.4264743 | 4.72 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 540.4457071 | 5.63 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 540.4457119 | 9.09 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 540.4457913 | 8.7 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 540.4458006 | 11.9 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 540.4458183 | 8.78 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 540.4458534 | 6.82 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 541.4294163 | 4.72 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 549.4869701 | 8.64 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 551.5050131 | 9.01 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 551.5050348 | 9.03 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 551.5053641 | 8.69 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 551.5059239 | 9.39 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 554.4405045 | 5.19 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 556.4409865 | 9.15 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 556.441058 | 8.1 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 559.516438 | 7.61 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 560.5064605 | 6.47 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 561.5065937 | 6.47 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 561.5226887 | 7.35 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 562.3153246 | 2.91 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 563.5402431 | 9.47 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 563.5402611 | 9.43 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 563.5403825 | 9.06 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 566.5690282 | 12.09 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 566.5690512 | 11.71 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 567.5714346 | 8.13 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 568.4564621 | 5.38 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 570.4565237 | 10.84 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 570.4565953 | 11.39 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 570.4566149 | 8.98 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 570.4566301 | 9.38 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 570.4567103 | 7.72 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 572.435857 | 2.77 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 575.4988081 | 8.31 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 575.4990961 | 8.58 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 577.5168495 | 6.04 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 577.5173418 | 6.55 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 577.5178047 | 8.61 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 577.5179583 | 9.45 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 577.5180448 | 9.28 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 577.5183425 | 8.9 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 579.5368458 | 8.94 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 579.537308 | 9.37 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 583.5866279 | 7.65 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 591.5713653 | 9.88 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 593.5968499 | 9.31 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 594.5999381 | 11.16 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 594.6000583 | 9.46 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 594.6000988 | 7.94 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 596.6028398 | 7.74 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 601.5202331 | 8.84 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 601.5205466 | 8.54 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 601.5214504 | 8.29 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 601.52198 | 8.54 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 601.5264124 | 5.17 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 601.5265437 | 5.3 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 603.527841 | 6.03 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 603.5307004 | 9.02 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 603.5319156 | 8.82 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 604.5363563 | 8.82 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 605.5472527 | 6.45 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 605.5483191 | 6.95 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 610.6230785 | 8.1 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 610.623192 | 9.22 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 614.482715 | 11.39 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 614.4827677 | 7.27 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 614.4828082 | 8.18 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 621.309882 | 4.15 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 624.6331094 | 9.96 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 625.4089898 | 4.71 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 627.5337539 | 5.95 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 627.5338558 | 6.47 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 629.5544768 | 6.08 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 629.5545018 | 6.23 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 630.6156258 | 7.56 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 631.5595216 | 6.47 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | Cer(d42:1) | 632.6325885 | 7.93 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 637.3046243 | 3.27 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 638.3363102 | 4.15 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 638.6541331 | 11.65 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 642.4357388 | 4.72 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 643.2916856 | 4.15 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 644.5949682 | 7.63 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 647.458279 | 7.32 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 647.4582993 | 7.46 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 647.4583194 | 8.85 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 647.4583721 | 8.64 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | Cer(d18:1/24:1) | 648.6274 | 7.55 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | Cer(d18:1/24:0) | 650.6433747 | 7.93 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 653.4401563 | 5.23 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 654.3311573 | 3.27 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 663.4528578 | 9.42 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 665.4592971 | 10.8 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 665.4595172 | 9.3 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 668.5961627 | 7.21 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 670.4668271 | 5.23 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 670.6101251 | 7.55 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 672.6255249 | 7.93 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 674.5100778 | 6.34 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | SM(d32:1) | 675.5387425 | 5.51 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 678.5052346 | 5.46 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 679.4177312 | 3.27 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 680.4792741 | 10.36 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 681.4817016 | 10.91 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 681.4818053 | 11.08 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 690.5055831 | 6.12 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 692.5209235 | 6.58 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 692.5577577 | 6.29 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 694.3986036 | 4.15 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 700.5263956 | 6.38 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | SM(d16:1/18:1) or SM(d18:2/16:0) | 701.5577646 | 5.56 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 702.5390906 | 6.77 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | SM(d34:1) | 703.573556 | 6.06 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 704.5209737 | 5.51 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 704.5210576 | 5.48 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | SM(d18:0/16:0) | 705.5855553 | 6.25 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | PC(30:0) | 706.5374421 | 5.98 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 710.6282378 | 7.65 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 711.4932531 | 5.23 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 712.6433572 | 7.94 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PE(34:2) | 716.5227648 | 6.15 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | SM(d35:1) | 717.5895045 | 5.93 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | PE(16:0/18:1) | 718.5377644 | 6.56 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | PC(O-32:1) | 718.5768493 | 6.65 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | PC(31:0) | 720.5532228 | 6.23 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | PE(34:0) | 720.5533119 | 6.99 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | PC(O-32:0) | 720.5899998 | 6.75 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 721.506188 | 6.51 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 721.506256 | 7.22 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 722.5157338 | 6.3 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 722.5162351 | 6.52 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 722.5191761 | 7.42 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 722.5903664 | 6.75 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 723.5256003 | 10.49 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 723.5257656 | 11.63 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 723.5259647 | 10.72 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 723.5846842 | 4.84 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 723.5847856 | 4.65 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 724.5905082 | 4.83 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 724.5905129 | 4.65 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 725.5554541 | 6.06 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 726.5389608 | 6.33 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 726.5407153 | 6.44 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 727.5692282 | 6.27 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PC(32:2) | 730.537036 | 5.56 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 730.573314 | 7.14 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 731.5402816 | 5.54 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | SM(d36:1) | 731.6043309 | 6.57 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | PC(32:1) | 732.5526166 | 5.99 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | PC(16:0/16:0) | 734.5681568 | 6.46 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | PC(31:0(OH)) | 736.5419043 | 6.22 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 738.6590117 | 7.89 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PE(36:4) | 740.5260094 | 6.03 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 740.6746975 | 8.18 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 741.553261 | 6.54 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 741.5986036 | 7.64 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 742.5367579 | 6.16 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PC(O-34:3) | 742.5759441 | 6.31 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 743.5530734 | 6.54 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 743.6154896 | 7.9 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 744.5541694 | 6.55 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PC(O-34:2) | 744.5882618 | 6.33 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 745.5566044 | 6.55 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 745.6337973 | 8.19 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 746.5095384 | 6.23 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PC(33:1) | 746.5656202 | 6.22 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 746.5663044 | 6.97 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PC(16:0e/18:1(9Z)) | 746.6045999 | 6.71 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 748.5263766 | 6.04 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PC(33:0) | 748.5835898 | 6.61 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 748.6194267 | 7.14 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PE(O-16:0/22:6) or PE(P-18:0/20:5) | 750.5360889 | 6.22 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 751.6183898 | 5.34 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 751.6184317 | 5.54 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PE(O-38:5) or PE(P-38:4) | 752.5564821 | 6.55 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 754.5718978 | 6.84 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 756.5502182 | 5.97 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PC(34:3) | 756.5531395 | 5.57 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | PC(34:2) | 758.5685023 | 6.04 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 759.5716798 | 6.03 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 760.5791116 | 6.03 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PC(16:0/18:1) | 760.5839876 | 6.44 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 762.5942771 | 6.44 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 763.5927258 | 6.44 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 764.6744296 | 7.89 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 766.5365684 | 6.02 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 766.5701078 | 6.31 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 766.6904117 | 8.15 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 768.5531237 | 6.24 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PE(38:4) | 768.5531593 | 6.47 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | PC(O-36:4) | 768.5866952 | 6.2 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(16:0/16:0/12:0) | 768.705939 | 8.44 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 769.5846084 | 6.95 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 770.5692003 | 6.67 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PC(O-36:3) | 770.6034344 | 6.4 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 771.5843855 | 6.95 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 771.6456479 | 8.15 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PC(35:2) | 772.5834189 | 6.22 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 772.5863444 | 6.95 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PC(18:0p/18:1(9Z)) | 772.6190176 | 6.72 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 773.6646925 | 8.44 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PC(35:1) | 774.5989406 | 6.64 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 779.6121504 | 6.26 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 780.5501372 | 6.04 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PC(36:5) | 780.551818 | 5.53 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | PC(36:4) | 782.5674609 | 5.64 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | PC(36:3) | 784.582836 | 6.03 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 786.5939345 | 6.07 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 786.5945771 | 6.06 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PC(36:2) | 786.5993594 | 6.43 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 787.6022348 | 6.43 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 787.6204252 | 8.14 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | SM(d40:1) | 787.6665656 | 7.39 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | PC(36:1) | 788.6130258 | 6.85 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | PC(18:0/18:0) | 790.6297916 | 7.25 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 792.5563455 | 6.27 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(16:0/18:2/12:0) | 792.7061207 | 8.13 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | PC(O-38:5) | 794.6039473 | 6.18 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 794.7193645 | 8.13 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(16:1/18:1/12:0) | 794.7218393 | 8.39 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 796.5843776 | 6.74 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(46:0) | 796.7373341 | 8.72 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 799.677418 | 8.39 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 801.272918 | 5.57 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 804.5505473 | 5.91 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 806.5664183 | 6.07 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PC(38:6) | 806.5680835 | 5.5 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 808.5801805 | 6.42 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PC(38:5) | 808.5831581 | 5.9 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(47:1) | 808.7375183 | 8.53 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 808.7738609 | 9.11 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PC(38:4) | 810.5985893 | 6.12 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(47:0) | 810.7527279 | 8.85 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 810.7891395 | 9.58 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | SM(d42:3) | 811.6670925 | 6.91 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | PC(38:3) | 812.6149907 | 6.46 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 813.6359681 | 8.13 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | SM(d42:2) | 813.6806343 | 6.95 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 813.7293189 | 9.11 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PC(38:2) | 814.629942 | 6.81 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 815.6522475 | 8.39 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | SM(d42:1) | 815.6940789 | 7.36 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 815.6941534 | 7.31 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | SM(d18:1/24:0) | 815.6976576 | 7.73 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | PC(38:1) | 816.6453526 | 7.19 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 816.7020765 | 7.74 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(48:3) | 818.7209946 | 8.12 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(18:1/12:0/18:1) or TG(18:2/16:0/14:0) | 820.7380083 | 8.37 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 822.5218874 | 6 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(14:0/16:0/18:1) | 822.7532415 | 8.66 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 823.6774969 | 8.12 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 824.5405978 | 6.45 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 824.76485 | 8.67 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(16:0/16:0/16:0) | 824.768106 | 9.03 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 825.6928961 | 8.37 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 827.7055112 | 8.38 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(48:1) | 827.7081502 | 8.66 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 828.2838826 | 5.57 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(48:0) | 829.7242018 | 9.03 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 832.5817367 | 6.34 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 832.6627058 | 7.29 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PC(40:6) | 834.5992768 | 6.2 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 834.6769094 | 7.67 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(49:2) | 834.7535735 | 8.5 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 834.7892778 | 9.07 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 835.6646745 | 7.31 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | PC(40:5) | 836.6133266 | 6.24 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(49:1) | 836.7693396 | 8.8 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(O-50:1) or TG(P-50:0) | 836.8051789 | 9.49 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(49:0) | 838.7852679 | 9.19 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 839.6947116 | 7.3 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 839.708848 | 8.5 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 841.6669032 | 8.36 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 841.7607487 | 9.47 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 843.6828866 | 8.66 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 844.2786118 | 4.16 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(14:0/18:2/18:2) | 844.7364279 | 8.1 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 845.6987551 | 9.03 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 848.5393434 | 6.02 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 848.7661462 | 8.34 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(14:0/18:1/18:1) | 848.7688747 | 8.61 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 849.6920102 | 8.1 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 849.6926547 | 8.15 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 850.2661785 | 5.57 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 850.5537208 | 6.44 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 850.7809663 | 8.62 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(50:1) | 850.7841038 | 8.95 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(50:3) | 851.7084081 | 8.33 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 852.7953889 | 8.95 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(50:0) | 852.799312 | 9.38 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(50:2) | 853.7242299 | 8.61 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 855.7399816 | 8.95 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 856.4561685 | 6.73 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 858.2945493 | 4.15 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(51:3) | 860.7681917 | 8.47 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | LacCer(d18:1/16:0) | 862.6240905 | 5.99 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(O-52:2) or TG(P-52:1) | 862.8203445 | 9.37 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 863.6889193 | 7.92 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(51:1) | 864.8006375 | 9.11 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 865.7248066 | 8.48 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 866.2399654 | 5.57 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 867.6827905 | 8.34 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(51:2) | 867.7399112 | 8.74 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(52:6) | 868.7366446 | 7.95 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 869.6982399 | 8.62 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(16:0/18:2/18:3) | 870.7441078 | 8.11 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 871.7141989 | 8.95 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(16:0/18:2/18:2) | 872.7706007 | 8.31 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(18:2/18:1/16:0) | 874.7833852 | 8.57 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(52:5) | 875.7042982 | 8.11 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 876.5659533 | 6.41 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 876.79591 | 8.57 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(18:1/18:1/16:0) | 876.7999457 | 8.88 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(52:4) | 877.7240613 | 8.31 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 878.8101913 | 8.88 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(16:0/18:0/18:1) | 878.8138369 | 9.29 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(52:3) | 879.7395209 | 8.57 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 880.826405 | 9.29 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(52:0) | 880.8308873 | 9.78 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(52:2) | 881.7548095 | 8.88 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 883.770059 | 9.29 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(53:4) | 886.7836661 | 8.43 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(53:3) | 888.7994391 | 8.7 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(53:2) | 890.81465 | 9.03 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 892.4087139 | 8.36 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 892.828341 | 8.96 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 893.7249477 | 7.66 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 895.7137236 | 8.57 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 895.7362613 | 7.78 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(18:2/18:2/18:2) or TG(18:3/18:2/18:1) | 896.7686352 | 8.05 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 897.7296803 | 8.88 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(18:1/18:2/18:2) | 898.7819281 | 8.27 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 899.7454432 | 9.28 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(18:2/18:1/18:1) | 900.8002836 | 8.53 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(54:6) | 901.7245368 | 8.05 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 902.8113523 | 8.53 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(18:1/18:1/18:1) | 902.8152863 | 8.82 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(54:5) | 903.7366336 | 8.27 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 904.8259013 | 8.82 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(54:4) | 905.7552608 | 8.52 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 906.8413797 | 8.93 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(54:1) | 906.8445261 | 9.66 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(54:3) | 907.771133 | 8.82 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(18:0/18:0/18:0) | 908.861538 | 10.24 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 909.5451128 | 5.95 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(54:2) | 909.785909 | 9.2 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 916.5248827 | 6.03 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 918.5405272 | 6.43 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 918.8440598 | 8.88 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 919.7115319 | 8.27 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(16:0/18:2/22:6) | 920.768257 | 8 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 921.7293737 | 8.53 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 922.0098373 | 5.15 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(18:2/22:5/16:0) | 922.7830166 | 8.1 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 923.745411 | 8.82 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(16:0/22:5/18:1) or TG(20:4/18:1/18:1) | 924.7996014 | 8.33 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 925.7247551 | 8.01 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 925.7607727 | 9.2 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(56:5) | 926.8122605 | 8.51 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(18:0/18:1/20:4) | 926.8138309 | 8.61 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 927.7396955 | 8.1 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 927.739709 | 8.19 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 927.7398504 | 8.14 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(56:4) | 928.8305812 | 8.82 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(56:6) | 929.7545897 | 8.32 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 929.7547641 | 8.29 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 930.8438183 | 8.57 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(56:3) | 930.8463323 | 9.11 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 931.7678943 | 8.51 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 932.8605106 | 8.88 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(56:2) | 932.8617893 | 9.54 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 933.7861927 | 8.82 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 934.875418 | 10.06 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 935.8023458 | 9.12 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 937.8154017 | 9.54 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 940.8265872 | 8.29 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(58:9) | 946.7838994 | 7.98 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 947.7412794 | 8.5 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | TG(18:1/18:1/22:6) | 948.7994994 | 8.19 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | TG(58:6) | 952.8302672 | 8.54 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |
AN002734 | 953.7557954 | 8.19 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 958.878052 | 9.46 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 960.8934534 | 9.95 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 961.8164336 | 8.17 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 965.848921 | 9.94 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 989.8474599 | 8.42 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 1076.693479 | 8.61 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 1078.709214 | 8.95 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 1102.709097 | 8.57 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells | |
AN002734 | 1104.725036 | 8.88 | Minutes | ST001676 | POSITIVE | Agilent 6540 QTOF | Reversed phase | Human | T-cells |